Loss of CD20 expression in relapsed diffuse large b-cell lymphoma: Clinical significance of an uncommon pathological finding

被引：0
|
作者：
Mitra, Subhashis [1 ]
Mukherjee, Sanghamitra [1 ]
Bhattacharyya, Maitreyee [2 ]
Chakraborty, Hema [1 ]
机构：
[1] AMRI Hosp, Dept Pathol, Kolkata 700029, W Bengal, India
[2] Med Coll & Hosp, Inst Hematol & Transfus Med, Kolkata, W Bengal, India
来源：
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY | 2016年 / 59卷 / 02期
关键词：
COMBINATION;
D O I：
10.4103/0377-4929.182026
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：263 / 265
页数：3
相关论文
共 50 条
  • [41] Management of Relapsed Diffuse Large B-Cell Lymphoma
    Kenkre, Vaishalee Padgaonkar
    Smith, Sonali M.
    CURRENT ONCOLOGY REPORTS, 2008, 10 (05) : 393 - 403
  • [42] Management of relapsed diffuse large B-cell lymphoma
    Vaishalee Padgaonkar Kenkre
    Sonali M. Smith
    Current Oncology Reports, 2008, 10 : 393 - 403
  • [43] Prognostic significance of CD30 expression in patients with diffuse large B-cell lymphoma
    Kanemasa, Yusuke
    Shimoyama, Tatsu
    Sasaki, Yuki
    Tamura, Miho
    Sawada, Takeshi
    Omuro, Yasushi
    Hishima, Tsunekazu
    Maeda, Yoshiharu
    ANNALS OF ONCOLOGY, 2017, 28
  • [44] Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression
    Davis, TA
    Czerwinski, DK
    Levy, R
    CLINICAL CANCER RESEARCH, 1999, 5 (03) : 611 - 615
  • [45] Lack of Utility of CD20 Immunohistochemistry in Staging Bone Marrow Biopsies for Diffuse Large B-cell Lymphoma
    Baiyee, Daniel
    Warnke, Roger
    Natkunam, Yasodha
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2009, 17 (02) : 93 - 95
  • [46] Clinical significance of the loss of CD20 antigen on tumor cells in patients with relapsed or refractory follicular lymphoma
    Michot, Jean-Marie
    Buet-Elfassy, Alice
    Annereau, Maxime
    Lazarovici, Julien
    Danu, Alina
    Sarkozy, Clementine
    Chahine, Claude
    Bigenwald, Camille
    Bosq, Jacques
    Rossignol, Julien
    Romano-Martin, Patricia
    Baldini, Capucine
    Ghez, David
    Dartigues, Peggy
    Massard, Christophe
    Ribrag, Vincent
    CANCER DRUG RESISTANCE, 2021, 4 (03) : 710 - 718
  • [47] Clinical Significance of CMYC Rearrangement in Diffuse Large B-Cell Lymphoma
    Caponetti, G. C.
    Dave, B.
    Smith, L.
    Meyer, P.
    Bast, M.
    Bierman, P.
    Bociek, G.
    Vose, J.
    Armitage, J. O.
    Aoun, P.
    Fu, K.
    Greiner, T.
    Chan, W. C.
    Weisenburger, D.
    LABORATORY INVESTIGATION, 2011, 91 : 288A - 288A
  • [48] Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma
    Wang, Xiaoxiao
    Cao, Xin
    Sun, Ruifang
    Tang, Charlene
    Tzankov, Alexandar
    Zhang, Jun
    Manyam, Ganiraju C.
    Xiao, Min
    Miao, Yi
    Jabbar, Kausar
    Tan, Xiaohong
    Pang, Yuyang
    Visco, Carlo
    Xie, Yan
    Dybkaer, Karen
    Chiu, April
    Orazi, Attilio
    Zu, Youli
    Bhagat, Govind
    Richards, Kristy L.
    Hsi, Eric D.
    Choi, William W. L.
    van Krieken, J. Han
    Huh, Jooryung
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Moller, Michael B.
    Parsons, Ben M.
    Winter, Jane N.
    Piris, Miguel A.
    Li, Shaoying
    Miranda, Roberto N.
    Medeiros, L. Jeffrey
    Li, Yong
    Xu-Monette, Zijun Y.
    Young, Ken H.
    NEOPLASIA, 2018, 20 (06): : 574 - 593
  • [49] CD30 Expression in Diffuse Large B-Cell Lymphoma
    Slack, Graham W.
    Steidl, Christian
    Sehn, Laurie H.
    Gascoyne, Randy D.
    BLOOD, 2012, 120 (21)
  • [50] Expression of CD30 in diffuse large B-cell lymphoma
    Liasnichaya, O. V.
    Malashenka, S. V.
    Katin, M. A.
    ANNALS OF ONCOLOGY, 2020, 31 : S1221 - S1221
12345